250 related articles for article (PubMed ID: 22177294)
1. Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.
Sabate M; García JR; Valls E; Moragas M; Soler M; Riera E; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):167-8. PubMed ID: 22177294
[No Abstract] [Full Text] [Related]
2. Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
Bawa M; Sidhu G; Galt JR; Schuster DM; Halkar RK
Clin Nucl Med; 2006 Jun; 31(6):347-8. PubMed ID: 16714898
[No Abstract] [Full Text] [Related]
3. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
4. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.
Wen JC; Sai V; Straatsma BR; McCannel TA
JAMA Ophthalmol; 2013 Jan; 131(1):56-61. PubMed ID: 23307209
[TBL] [Abstract][Full Text] [Related]
5. Whole body PET/CT for initial staging of choroidal melanoma.
Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
[TBL] [Abstract][Full Text] [Related]
6. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.
Freton A; Chin KJ; Raut R; Tena LB; Kivelä T; Finger PT
Eur J Ophthalmol; 2012; 22(2):236-43. PubMed ID: 21959680
[TBL] [Abstract][Full Text] [Related]
7. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
8. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
[TBL] [Abstract][Full Text] [Related]
9. 18FDG-PET/CT assessing the absence of cell viability and excluding metastatic disease in a case of necrotic choroidal melanoma.
Romero-Aroca P; Montero-Jaime M; Intriago B; Riu F; Peña-Gonzalez KB; Almena-Garcia M
Eur J Ophthalmol; 2012; 22(2):288-92. PubMed ID: 21725939
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
[TBL] [Abstract][Full Text] [Related]
11. Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
Ghazali N; Collyer JC; Tighe J
Int J Oral Maxillofac Surg; 2012 Jan; 41(1):5-8. PubMed ID: 22024137
[TBL] [Abstract][Full Text] [Related]
12. [FDG uptake in gall bladder in the PET and PET/CT scan of three oncology patients].
Núñez R; Yeung HW; Swanston NM; Macapinlac HA
Rev Esp Med Nucl; 2007; 26(4):234-6. PubMed ID: 17662192
[No Abstract] [Full Text] [Related]
13. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
14. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
16. Intramedullary metastasis detected with 18F FDG-PET/CT.
Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
[No Abstract] [Full Text] [Related]
17. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
18. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
[TBL] [Abstract][Full Text] [Related]
19. [Low diagnostic yield of the 11C-choline PET/CT in the detection of liver metastasis from prostate cancer].
García JR; Franquet E; Romera N; Moragas M; Jorcano S; Moragas G
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):56-7. PubMed ID: 24125594
[No Abstract] [Full Text] [Related]
20. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]